Noninvasive assessment of characteristics of novel anti-HER2

Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death

Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition

IJMS, Free Full-Text

Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model

Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)

Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence - ScienceDirect

Frontiers Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission

Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model

Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer